OBJECTIVES: Extreme @entity4346 ( @entity4346 ) is a known risk factor for @entity1164 in @entity1121 ( @entity1121 ). Extreme @entity8158 ( @entity8158 ) is rare, and whether it is linked to a poor outcome is unknown. This study was designed to investigate differences between @entity1121 @entity1 with extreme @entity8158 and those with extreme @entity4346 . METHODS: Among 2,413 @entity1121 @entity1 , 31 with extreme @entity8158 (maximum right ventricular wall thickness >= 10 mm) and 194 with extreme @entity4346 (maximum left ventricular wall thickness >= 30 mm) were investigated. The main clinical features and natural history were compared between the 2 groups. RESULTS: The prevalence of extreme @entity8158 and extreme @entity4346 was 1.3 and 8.0%, respectively. @entity1 with extreme @entity8158 tended to be younger and female (p < 0.01). Cardiovascular-related mortality and morbidity within 10 years were significantly greater in the extreme @entity8158 group (p < 0.05). Multivariate analysis demonstrated 3 independent predictors for cardiovascular mortality - extreme @entity8158 , left ventricular end-diastolic dimension >= 50 mm, and age  <=18 years at baseline - and 2 for morbidity - extreme @entity8158 and @entity1163 . CONCLUSIONS: Compared with extreme @entity4346 , extreme @entity8158 was quite uncommon in @entity1121 and had a worse prognosis. A right ventricle examination should be performed in routine @entity1121 evaluation.

The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular XXXX .

@entity1164 :: ('MESH:D016757', 'Disease') :: ['sudden cardiac death'] @entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity1163 :: ('MESH:D013575', 'Disease') :: ['presyncope'] @entity8158 :: ('MESH:D017380', 'Disease') :: ['right ventricular hypertrophy', 'RVH'] @entity4346 :: ('MESH:D017379', 'Disease') :: ['left ventricular hypertrophy', 'LVH'] @entity1121 :: ('MESH:D002312', 'Disease') :: ['HCM', 'hypertrophic cardiomyopathy']
@entity1121 :: (MESH:D002312,Disease) :: ['Hypertrophic Cardiomyopathy']
